Status:
COMPLETED
Healing Abutment Materials on Matrix Metalloproteinase-8 Level in Peri-implant Crevicular Fluid
Lead Sponsor:
Alexandria University
Conditions:
Dental Implants
Eligibility:
All Genders
25-65 years
Phase:
NA
Brief Summary
Numerous materials are nowadays used in the fabrication of healing abutments to be used for dental implants. soft tissue response to different healing abutment materials is still to be unraveled. the ...
Eligibility Criteria
Inclusion
- Patients with no systemic and/or oral health disease
- absence of any lesions in the oral cavity
- wide band of keratinized tissue more than 1mm at implant site
Exclusion
- smoking more than 20 cigarettes per day
- localized radiation therapy of the oral cavity,
- antitumor chemotherapy, liver diseases, blood diseases, kidney diseases, immunosuppressed patients, patients taking corticosteroids, pregnancy, inflammatory and autoimmune diseases of the oral cavity
Key Trial Info
Start Date :
January 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2023
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT06034132
Start Date
January 1 2023
End Date
June 15 2023
Last Update
September 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Alexandria Faculty of Dentistry
Alexandria, Egypt